Gabay, C., Burmester, G. R., Strand, V., Msihid, J., Zilberstein, M., Kimura, T., . . . Boyapati, A. (2020). Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. Arthritis Res Ther.
Dyfyniad Arddull ChicagoGabay, Cem, et al. "Sarilumab and Adalimumab Differential Effects On Bone Remodelling and Cardiovascular Risk Biomarkers, and Predictions of Treatment Outcomes." Arthritis Res Ther 2020.
Dyfyniad MLAGabay, Cem, et al. "Sarilumab and Adalimumab Differential Effects On Bone Remodelling and Cardiovascular Risk Biomarkers, and Predictions of Treatment Outcomes." Arthritis Res Ther 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.